Kaleido Biosciences
$4.629876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.73 (-13.64%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell KLDO and other stocks, options, ETFs, and crypto commission-free!
About KLDO
Kaleido Biosciences, Inc. engages in the provision of healthcare services. It focuses on leveraging the microbiome organ to treat disease and improve human health. Read More It offers microbiome metabolic therapies (MMT) which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the organ's existing microbes. The company was founded by Geoffrey von Maltzahn and Noubar B. Afeyan in 2015 and is headquartered in Lexington, MA.
Employees
91
Headquarters
Lexington, Massachusetts
Founded
2015
Market Cap
158.49M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
118.42K
High Today
$5.19
Low Today
$4.55
Open Price
$5.00
Volume
138.37K
52 Week High
$19.00
52 Week Low
$2.82
Collections
KLDO Earnings
-$1.56
-$1.04
-$0.52
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected Apr 30, Pre-Market